Detecting and Preventing AD Focus of Products in Pipeline
One of the burning topics that industry and academic scientists, policymakers and patients will be discussing this week at a one-day forum focused on the primary hurdles to combating Alzheimer’s disease (AD), sponsored by the Pharmaceutical Research and Manufacturers of America, the Alzheimer’s Association and the Alzheimer’s Drug Discovery Foundation, will be how to accelerate the impact of pre-competitive collaborative partnerships to get products moving into clinical trials.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter